Skip to content

Drug interactions

Muromonab cd3 + Tofacitinib

Severity: Major

Muromonab cd3 and Tofacitinib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Muromonab-CD3 is a potent T-cell depleting immunosuppressant. Combined with tofacitinib it greatly increases the risk of serious and opportunistic infection.

What this interaction means in plain words

Muromonab cd3 and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive immunosuppression from T-cell depletion and JAK inhibition.

What to do

Avoid the combination. If tofacitinib must be continued, monitor closely for infection and consider prophylaxis per transplant or immunology protocols.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Muromonab cd3 and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Muromonab cd3 with Tofacitinib?

MediHelp rates the interaction as major. Muromonab cd3 and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Muromonab-CD3 is a potent T-cell depleting immunosuppressant. Combined with tofacitinib it greatly increases the risk of serious and opportunistic infection.

How serious is the interaction between Muromonab cd3 and Tofacitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination. If tofacitinib must be continued, monitor closely for infection and consider prophylaxis per transplant or immunology protocols.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in